Product
NNC0471-0119 A
1 clinical trial
2 indications
Indication
Diabetes MellitusIndication
Type 1Clinical trial
A Study Investigating the Pharmacokinetic and Pharmacodynamic Properties and Safety and Tolerability of Three Formulations of NNC0471-0119 When Administered as One Bolus in a Continuous Subcutaneous Insulin Infusion Regimen in Participants With Type 1 DiabetesStatus: Completed, Estimated PCD: 2022-08-29